ALLR
Allarity Therapeutics
ALLR
ALLR
hedge funds and large institutions have $694K invested in Allarity Therapeutics in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
ECM
ExodusPoint Capital Management
New York
|
$0 |
| 2 |
UBS Group
Zurich,
Switzerland
|
$9K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $233K | – | – | – |
|
2
Millennium Management
New York
| $192K | – | – | – |
|
|
LP
3
LMR Partners
London,
United Kingdom
| $105K | – | – | – |
|
4
Morgan Stanley
New York
| $65K | – | – | – |
|
|
BCM
5
Bridgeway Capital Management
Houston,
Texas
| $41K | – | – | – |
|
6
Geode Capital Management
Boston,
Massachusetts
| $25K | – | – | – |
|
7
Citigroup
New York
| $21K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $9K | -$1K | – | – |
|
9
Bank of America
Charlotte,
North Carolina
| $3K | – | – | – |
|
|
ECM
10
ExodusPoint Capital Management
New York
| – | -$269K | – | – |
|